We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer, ThromboGenics Receive Positive CHMP Opinions
The EMA’s Committee for Medicinal Products for Human Use (CHMP) released several drug approval recommendations from its January meeting, including a thumbs up for Pfizer’s chronic myelogenous leukemia (CML) drug Bosulif.